ZA976895B - Pharmaceutical composition comprising a coenzyme useful in the treatment of acquired immunodeficiency syndrome. - Google Patents

Pharmaceutical composition comprising a coenzyme useful in the treatment of acquired immunodeficiency syndrome.

Info

Publication number
ZA976895B
ZA976895B ZA9706895A ZA976895A ZA976895B ZA 976895 B ZA976895 B ZA 976895B ZA 9706895 A ZA9706895 A ZA 9706895A ZA 976895 A ZA976895 A ZA 976895A ZA 976895 B ZA976895 B ZA 976895B
Authority
ZA
South Africa
Prior art keywords
treatment
pharmaceutical composition
acquired immunodeficiency
immunodeficiency syndrome
coenzyme
Prior art date
Application number
ZA9706895A
Inventor
Raffaele Ansovini
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of ZA976895B publication Critical patent/ZA976895B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9706895A 1996-09-06 1997-08-01 Pharmaceutical composition comprising a coenzyme useful in the treatment of acquired immunodeficiency syndrome. ZA976895B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001834A IT1284139B1 (en) 1996-09-06 1996-09-06 PHARMACEUTICAL COMPOSITION INCLUDING A USEFUL COENZYME IN THE TREATMENT OF ACQUIRED IMMUNODEFICENCE SYNDROME

Publications (1)

Publication Number Publication Date
ZA976895B true ZA976895B (en) 1998-02-18

Family

ID=11374849

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9706895A ZA976895B (en) 1996-09-06 1997-08-01 Pharmaceutical composition comprising a coenzyme useful in the treatment of acquired immunodeficiency syndrome.

Country Status (5)

Country Link
AR (1) AR009513A1 (en)
AU (1) AU4457897A (en)
IT (1) IT1284139B1 (en)
WO (1) WO1998009634A1 (en)
ZA (1) ZA976895B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1401504B1 (en) 2010-08-02 2013-07-26 Cattarini Mastelli COMPOSITION INCLUDING GLUTATION AND REDUCTASE AND OXIDIZED GLUTATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222419A (en) * 1983-05-31 1984-12-14 Sankyo Co Ltd Cholesterol-lowering agent
US5051353A (en) * 1988-08-09 1991-09-24 The United States Of America As Represented By The Secretary Of The Navy Preservation and restoration of hemoglobin in blood substitutes
FR2715303A1 (en) * 1991-04-02 1995-07-28 Berque Jean Riboflavin for treating human immunodeficiency virus related diseases
EP0638315B1 (en) * 1993-08-13 1998-11-18 Nikolai Vasilievich Karsanov Antihypoxic agent
FR2718353B3 (en) * 1994-04-11 1996-06-28 Jean Berque Pharmaceutical compositions based on non-toxic biological products intended for the local protection of the genital and rectal mucosa.

Also Published As

Publication number Publication date
AR009513A1 (en) 2000-04-26
ITMI961834A1 (en) 1998-03-06
IT1284139B1 (en) 1998-05-08
AU4457897A (en) 1998-03-26
WO1998009634A1 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
USD390799S (en) Timer display
HK1010484A1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
ZA954943B (en) Insulin analog formulations.
EP0956854A4 (en) Pharmaceutical composition comprising coenzyme q 10
ZA9710071B (en) Pharmaceutical composition.
ZA9710927B (en) Pharmaceutical composition.
ZA972685B (en) Medicaments.
EP0683664A4 (en) Taxol formulation.
ZA9711508B (en) Rapidly disintegrable pharmaceutical composition.
HK1027957A1 (en) Pharmaceutical composition.
ZA964710B (en) Novel compounds, the preparation and use thereof.
ZA977104B (en) Pharmaceutical compositions.
ZA989680B (en) Pharmaceutical composition.
PH31073A (en) Pharmaceutical composition and process for the preparation thereof.
ZA968081B (en) Pharmaceutical composition.
ZA987392B (en) Pharmaceutical composition.
ZA961983B (en) Bicyclic compounds, preparation thereof and use in pharmaceutical compositions.
ZA972602B (en) Pharmaceutical compositions.
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
ZA976895B (en) Pharmaceutical composition comprising a coenzyme useful in the treatment of acquired immunodeficiency syndrome.
GB2285436B (en) Container,in particular a coffin or the like
ZA994697B (en) Pharmaceutical formulation.
ZA94434B (en) Pharmaceutical composition.
ZA99918B (en) Pharmaceutical formulation.